I TUOI DATI
I TUOI ORDINI
N. prodotti: 0
Totale ordine: € 0,00
I TUOI ABBONAMENTI
I TUOI ARTICOLI
Rivista di Chirurgia Cardiaca, Vascolare e Toracica
Indexed/Abstracted in: BIOSIS Previews, Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,632
REVIEWS BARE NITINOL STENTS IN PERIPHERAL ENDOVASCULAR INTERVENTIONS: IS THIS HISTORY? THE INFRAPOPLITEAL FIELD
The Journal of Cardiovascular Surgery 2016 Giugno;57(3):336-42
Covered stents in iliac artery occlusive disease: what is the evidence?
B. Patrice MWIPATAYI 1, 2, Elizabeth SUTHERS 1, Shannon D. THOMAS 3, 4, 5, Nishath ALTAF 1
1 Department of Vascular Surgery, Royal Perth Hospital, Perth, Australia; 2 School of Surgery, Faculty of Medicine, Dentistry and Health Sciences, University of Western Australia, Crawley, Australia; 3 Department of Vascular Surgery, Prince of Wales Hospital, Sydney, Australia; 4 Faculty of Medicine, University of New South Wales, Sydney, Australia; 5 The Vascular Institute, Prince of Wales Hospital, Sydney, Australia
The last two decades have seen a revolution in the treatment of aortoiliac occlusive disease (AIOD). Acceptable safety and durability outcomes have now been realized with endovascular treatments, which is increasingly finding a place in the treatment of AIOD. Evolution of stent technologies and endovascular techniques is seeing an expansion of AIOD lesions indicated for primary endovascular treatment. The literature evidence basis is continuously evolving, and questions remain as to the optimal form of vessel treatment. Covered stents have been increasingly promoted for their long-term durability, particularly in extensive, challenging AIOD lesions. Here, we explore the seminal evidence basis for covered stents in the treatment of AIOD, and aim to provide a sound evidence based argument for their use.